IR is a key contributor to cardiovascular disease in T1D but is difficult to measure. The relevance of mean overnight glycemia (MOG) in IR assessments by gold-standard hyperinsulinemic-euglycemic clamps (HEC) in T1D is unclear. We assessed the relationship between pre-HEC MOG and HEC-assessed IR in pubertal adolescents ages 12-19 yrs with T1D.

Each youth underwent admission with variable overnight intravenous insulin infusion titrated with a standardized protocol to a goal blood glucose (BG) of 100-120 mg/dL, followed by an AM HEC with 80mU/m2/min insulin infusion paired with a variable glucose infusion rate (GIR, 20% dextrose infusion, goal BG 95-100 mg/dL). MOG and insulin infusion rates were assessed overnight. Achieved MOG was categorized as ≤100, 101-120, and 121-140 mg/dL. IR was assessed by end-HEC steady-state GIR and free fatty acids (FFA).

80 youth (42 girls, 38 boys) with T1D enrolled (mean age 16 ± 2.1 yrs, HbA1c 8.4 ± 1.6%, T1D duration 6.9 ± 4.0 yrs, BMI 24.0 ± 4.7 kg/m2). Mean BG at end-HEC was 99.0 ± 7.4 mg/dL. Results categorized by MOG category are shown in the Table. As MOG category increased, overnight insulin infusion requirements and end-HEC FFA’s increased and GIR decreased.

In T1D, more difficult to control overnight BG in a controlled setting likely reflects greater overnight IR and HEC whole-body and adipose IR. Future directions include home overnight pump/CGM-based simpler methods for assessing IR in T1D.

Disclosure

M.G. Cree: Consultant; Pollie, Inc. Research Support; Amino Co. A. Bernard: None. A. Baumgartner: None. A. Hines: None. A. Bailey: None. G. Carey: None. L. Pyle: None. J.K. Snell-Bergeon: None. K.J. Nadeau: None.

Funding

American Diabetes Association (7-11-CD-08); JDRF (2-SRA-2022-1144-M-B)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.